摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4-fluorophenyl)-[1-[3-[(4Z)-4-hydroxyimino-5-methyl-1,1-dioxo-3H-pyrrolo[2,3-e]thiazin-2-yl]propyl]piperidin-4-yl]methanone

中文名称
——
中文别名
——
英文名称
(4-fluorophenyl)-[1-[3-[(4Z)-4-hydroxyimino-5-methyl-1,1-dioxo-3H-pyrrolo[2,3-e]thiazin-2-yl]propyl]piperidin-4-yl]methanone
英文别名
——
(4-fluorophenyl)-[1-[3-[(4Z)-4-hydroxyimino-5-methyl-1,1-dioxo-3H-pyrrolo[2,3-e]thiazin-2-yl]propyl]piperidin-4-yl]methanone化学式
CAS
——
化学式
C22H27FN4O4S
mdl
——
分子量
462.5
InChiKey
ABVYFXPRQFNPLE-CLCOLTQESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    32
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.45
  • 拓扑面积:
    104
  • 氢给体数:
    1
  • 氢受体数:
    8

文献信息

  • Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonistic and alpha-1-blocking action
    申请人:SUNTORY LIMITED
    公开号:US20020040017A1
    公开(公告)日:2002-04-04
    A pyrrolesulfonamide derivative having the following formula (I): 1 wherein the ring P represented by 2 is a pyrrole ring having the following structure: 3 wherein R represents alkyl, cycloalkyl, cycloalkylalkyl or aralkyl; the dashed line indicates the presence or absence of a bond; and, when the bond is present, Z 2 is not present and Z 1 represents H but, when the bond is absent, Z 1 represents H and Z 2 represents OH or Z 1 and Z 2 are combined together to represent O or a group NOR 1 , in which R 1 represents H, or alkyl, aralkyl or aryl; l stands for 0 or 1; A represents alkylene, alkenylene or alkynylene; and Y represents a group 4 in which W represents CH, C═ or N; m stands for 0 or 1 when W is CH or N, or m stands for 1 when W is C═; B represents a specific divalent group; E 1 and E 2 each independently represents H or lower alkyl; and D represents an aromatic hydrocarbon group or heterocyclic group. The compound (I) has strong serotonin-2 receptor antagonistic action and low toxicity and less side effects, and is useful as a therapeutic for circulatory diseases such as ischemic heart diseases, cerebrovascular disturbances and peripheral circulatory disturbances.
    具有以下式子(I)的吡咯磺酰胺衍生物:其中由2表示的环P是具有以下结构的吡咯环:其中R代表烷基,环烷基,环烷基烷基或芳基烷基;虚线表示键的存在或不存在;当键存在时,Z2不存在且Z1代表H,但当键不存在时,Z1代表H且Z2代表OH或Z1和Z2组合在一起表示O或NOR1基团,其中R1代表H,或烷基,芳基烷基或芳基;l代表0或1;A代表烷基,烯基或炔基;Y代表一个含有4的基团,其中W代表CH,C═或N;当W为CH或N时,m代表0或1,当W为C═时,m代表1;B表示特定的二价基团;E1和E2分别表示H或低烷基;D表示芳香族烃基或杂环基团。化合物(I)具有强烈的5-羟色胺2受体拮抗作用,毒性低,副作用少,可用于治疗缺血性心脏病,脑血管障碍和外周循环障碍等循环系统疾病。
  • PYRROLOTHIAZINE AND PYRROLOTHIAZEPHINE COMPOUNDS HAVING SEROTONIN-2 RECEPTOR ANTAGONISTIC AND ALPHA-1-BLOCKING ACTION
    申请人:MIZUNO Akira
    公开号:US20050038242A2
    公开(公告)日:2005-02-17
    Abstract of the Disclosure A pyrrolesulfonamide derivative, Compound (I), which has strong serotonin-2 receptor antagonistic action and low toxicity and less side effects, and is useful as a therapeutic for circulatory diseases such as ischemic heart diseases, cerebrovascular disturbances and peripheral circulatory disturbances.
    本发明涉及一种吡咯磺酰胺衍生物,化合物(I),其具有强烈的5-羟色胺2受体拮抗作用,毒性低且副作用较少,可用于治疗循环系统疾病,如缺血性心脏病、脑血管障碍和周围循环障碍。
  • US6271223B1
    申请人:——
    公开号:US6271223B1
    公开(公告)日:2001-08-07
  • US6624314B2
    申请人:——
    公开号:US6624314B2
    公开(公告)日:2003-09-23
  • US7057036B2
    申请人:——
    公开号:US7057036B2
    公开(公告)日:2006-06-06
查看更多